Vasodilator prostanoids compensate for attenuated nitric oxide mediated vasodilation in type 1 diabetes

British Journal of Diabetes and Vascular Disease

Volumn 7, Issue 6, 2007, Pages 288-294

  Browne, Duncan L ^a   Meeking, Darryl R ^a   Allard, Sharon ^a   Munday, Linda J ^a   Shaw, Kenneth M ^a   Cummings, Michael H ^a  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

Acetylcholine; Endothelium; Nitric oxide; Prostaglandins; Type 1 diabetes

Indexed keywords

ACETYLCHOLINE; HEMOGLOBIN A1C; INDOMETACIN; N(G) METHYLARGININE; NITRIC OXIDE; PROSTANOID;

ADULT; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENDOTHELIAL DYSFUNCTION; FEMALE; FOREARM BLOOD FLOW; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PLETHYSMOGRAPHY; QUANTITATIVE ANALYSIS; VASODILATATION;

EID: 37849050777     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/14746514070070060601     Document Type: Article

References (37)

1. Krolewski AS, Kosinski EJ, Warram JH et al. Magnitude and Determinants of Coronary Artery Disease in Juvenile-Onset, Insulin-Dependent Diabetes Mellitus. Am J Cardiol 1987; 59:750-5.
2. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet ii 1989:997-1000.
3. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992;90:2548-54.
4. Abrams J. Role of endothelial dysfunction in coronary artery disease. Am J Cardiol 1997;79(12B):2-9.
5. Neunteufl T, Heher S, Katzenschlager R et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000;86:207-10.
6. Meeking DR, Browne DL, Allard S et al. Effects of cyclo-oxygenase inhibition on vasodilatory response to acetylcholine in patients with type 1 diabetes and nondiabetic subjects. Diabetes Care 2000; 23:1840-3.
7. Wotherspoon F, Laight DW, Browne DL et al. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria. Diabetic Med 2006; 23:1350-6.
8. O'Driscoll G, Green D, Rankin J et al. Improvements in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest 1997; 100:678-84.
9. Johnstone MT, Creager SJ, Scales KM et al. Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus. Circulation 1993:88:2510-16.
10. Stehouwer CD, Lambert J, Donker AJ, van Hinsbergh VW. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997;34(1):55-68.
11. Elliott TG, Cockcroft JR, Groop P-H et al. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993;85:687-93.
12. O'Byrne SO, Forte P, Roberts J et al. Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes 2000;49:857-62.
13. Duffy SJ, New G, Tran BT et al. Relative contribution of vasodilator prostanoids and NO to metabolic vasodilation in the human forearm. Am J Physiol 1999;276(2 Pt 2):H663-H670.
14. Tesfamariam B, Brown ML, Deykin D, Cohen RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 1990;85:929-32.
15. Dogra G, Rich L, Stanton K, Watts GF. Endothelium-dependent and independent vasodilation studied at normoglycaemia in Type 1 diabetes mellitus with and without microalbuminuria. Diabetologia 2001; 44:593-601.
16. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arterial tone in man. Lancet 1989; 2:997-1000.
17. Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation 1997; 95:2293-7.
18. Timimi FK, Ting HH, Hayley et al. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998;31:552-7.
19. Macklin AV, Viberti GC, Ritter J. Forearm blood flow in type 1 diabetics during systemic hyperglycemia. Diabetologia 1998; 41(1):A310.
20. Rubanyi GM, McKinney M, Vanhoutte PM. Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterisation of muscurinic receptors. J Pharmacol Exp Ther 1987;240:802-08.
21. Chan NN, Vallance P, Colhoun HM. Nitric oxide and vascular responses in Type I diabetes. Diabetologia 2000;43:137-47.
22. van Veen S, Chang PC. Prostaglandin and nitric oxide mediate insulin-induced vasodilation in the human forearm. Cardiovasc Res 1997;34:223-9.
23. Dawes M, Chowienczyk PJ, Ritter JM. Quantitative aspects of the inhibition by N(G)-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature. Br J Pharmacol 2001;134:939-44.
24. Skyrme-Jones RAP, O'Brien RC, Meredith IT. Vasodilator prostanoids, but not nitric oxide, may account for skeletal muscle hyperaemia in Type 1 diabetes mellitus. Clinical Science 2000;99:383-92.
25. Schade DS, Eaton RP, Freidman N, Spencer W. The intravenous, intraperitoneal and subcutaneous routes of insulin delivery in diabetic man. Diabetes 1979;28:1069-72.
26. Gonzalez E, Rosello-Catafau J, Jawerbaum A et al. Involvement of inducible isoforms of COX and NOS in streptozotocin-pancreatic damage in the rat: interactions between nitridergic and prostanoid pathway. Prostaglandins Leukot Essent Fatty Acids 2001;64:311-16.
27. Honing MLH, Smits P, Morrison PJ et al. Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarisation. Hypertension 2000; 35:1314-18.
28. Taddei S, Versari D, Cipriano A et al. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. JACC 2006;48:508-15.
29. Rajagopalan S, Kurz S, Munzel T et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations in vasomotor tone. J Clin Invest 1996;97:1916-23.
30. Cardillo C, Kilcoyne CM, Cannon RO et al. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Hypertension 2000;35:1237-41.
31. Drury PL, Smith GM, Ferriss JB. Increased vasopressor responsiveness to angiotensin II in type 1 (insulin dependent) diabetic patients without complications. Diabetologia 1984;27:174-9.
32. McIntyre C, Hadoke PWF, Williams BC et al. Selective enhancement of sensitivity to endothelin-1 despite normal endothelium-dependent relaxation in subcutaneous resistance arteries isolated from patients with Type 1 diabetes. Clinical Science 2001;100:311-18.
33. Butler R, Morris AD, Burchell B, Struthers AD. DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension 1999;33:1164-8.
34. Zanetti M, Sato J, Katusic ZS, O'Brien T. Gene transfer of endothelial nitric oxide synthase alters endothelium-dependent relaxations in aortas from diabetic rabbits. Diabetologia 2000;43:340-7.
35. Bush DE, Jones CE, Bass KM et al. Estrogen replacement reverses endothelial dysfunction in postmenopausal women. Am J Med 1998; 104:552-8.
36. Ishii H, Jirousek MR, Koya D et al. Amelioration of vascular dysfunction in diabetic rats by an oral PKC-beta inhibitor. Science 1996;272:728-31.
37. Mutus B, Rabini RA, Staffolani R et al. Homocysteine-induced inhibition of nitric oxide production study on healthy and diabetic subjects. Diabetologia 2001;44:979-82.